Predictive value of machine learning for PD-L1 expression in NSCLC: a systematic review and meta-analysis.
Journal:
World journal of surgical oncology
Published Date:
May 22, 2025
Abstract
BACKGROUND: As machine learning (ML) continuously develops in cancer diagnosis and treatment, some researchers have attempted to predict the expression of programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC) by ML. However, there is a lack of systematic evidence on the effectiveness of ML.